Medicine (Baltimore) 2015 May;94(21):e853
From the Chair of Medical Biotechnology, University of Medical Sciences (JM, ML, MK, MW, MZ, AM); Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre (JM, A-KD, MW, AM); Department of Medical and Experimental Oncology, Clinical Hospital of Poznan University of Medical Sciences, Poznan, Poland (JM); Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium (TB); Biochemisches Institut, University Kiel, Kiel, Germany (SR-J); and BioContract Sp z o.o., Poznan, Poland (ML, MK, AM).